Editing British American Tobacco
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 1,923: | Line 1,923: | ||
The U.S. Food & Drug Administration announced that, for the first time, it has authorized the marketing of products through the modified risk tobacco product pathway. The authorizations are for eight Swedish Match USA, Inc. snus smokeless tobacco products sold under the “General” brand name. The action further authorized the manufacturer to market these specific products with the claim “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”<ref>FDA website, [https://web.archive.org/save/https://www.fda.gov/news-events/press-announcements/fda-grants-first-ever-modified-risk-orders-eight-smokeless-tobacco-products FDA grants first-ever modified risk orders to eight smokeless tobacco products], 22 October 2019, Accessed 26 November 2019 </ref> | The U.S. Food & Drug Administration announced that, for the first time, it has authorized the marketing of products through the modified risk tobacco product pathway. The authorizations are for eight Swedish Match USA, Inc. snus smokeless tobacco products sold under the “General” brand name. The action further authorized the manufacturer to market these specific products with the claim “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”<ref>FDA website, [https://web.archive.org/save/https://www.fda.gov/news-events/press-announcements/fda-grants-first-ever-modified-risk-orders-eight-smokeless-tobacco-products FDA grants first-ever modified risk orders to eight smokeless tobacco products], 22 October 2019, Accessed 26 November 2019 </ref> | ||
− | ===Heated Cigarettes | + | ===Heated Cigarettes=== |
− | |||
− | |||
− | |||
− | |||
− | |||
British American Tobacco launched the new glo hyper X2 in Tokyo, Japan. <ref> Convenience store, [https://www.conveniencestore.co.uk/products/bat-launches-new-glo-hyper-x2/669718.article BAT launches new glo hyper x2], 21 July 2022, Accessed 19 August 2022 </ref> BAT Rothmans launched the new tobacco heating product Glo Pro Slim in South Korea. <ref>[http://web.archive.org/save/http://m.koreaherald.com/amp/view.php?ud=20210927000842 BAT unveils glo pro slim in Korea], ''Korea Herald'', 27 September 2021, Accessed 1 October 2021 </ref> | British American Tobacco launched the new glo hyper X2 in Tokyo, Japan. <ref> Convenience store, [https://www.conveniencestore.co.uk/products/bat-launches-new-glo-hyper-x2/669718.article BAT launches new glo hyper x2], 21 July 2022, Accessed 19 August 2022 </ref> BAT Rothmans launched the new tobacco heating product Glo Pro Slim in South Korea. <ref>[http://web.archive.org/save/http://m.koreaherald.com/amp/view.php?ud=20210927000842 BAT unveils glo pro slim in Korea], ''Korea Herald'', 27 September 2021, Accessed 1 October 2021 </ref> |